HL Financial Services LLC increased its position in Shire PLC (NASDAQ:SHPG) by 0.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,527 shares of the biopharmaceutical company’s stock after buying an additional 2 shares during the period. HL Financial Services LLC’s holdings in Shire PLC were worth $252,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of SHPG. HPM Partners LLC bought a new position in shares of Shire PLC during the first quarter worth approximately $1,534,000. Vanguard Group Inc. raised its position in shares of Shire PLC by 0.9% in the first quarter. Vanguard Group Inc. now owns 1,542,634 shares of the biopharmaceutical company’s stock worth $268,773,000 after buying an additional 13,665 shares during the period. BlackRock Inc. raised its position in shares of Shire PLC by 4,217.7% in the first quarter. BlackRock Inc. now owns 1,433,475 shares of the biopharmaceutical company’s stock worth $249,755,000 after buying an additional 1,400,275 shares during the period. Laurion Capital Management LP bought a new position in shares of Shire PLC during the first quarter worth approximately $10,611,000. Finally, Atria Investments LLC raised its position in shares of Shire PLC by 32.6% in the second quarter. Atria Investments LLC now owns 1,648 shares of the biopharmaceutical company’s stock worth $272,000 after buying an additional 405 shares during the period. 20.22% of the stock is currently owned by institutional investors and hedge funds.

Shire PLC (NASDAQ SHPG) opened at 147.71 on Wednesday. Shire PLC has a one year low of $147.28 and a one year high of $209.22.

Shire PLC (NASDAQ:SHPG) last released its earnings results on Thursday, August 3rd. The biopharmaceutical company reported $3.73 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.53 by $0.20. The company had revenue of $3.75 billion for the quarter. Shire PLC had a net margin of 4.70% and a return on equity of 14.10%. Shire PLC’s quarterly revenue was up 54.2% compared to the same quarter last year. During the same quarter last year, the company earned $3.38 earnings per share. Equities analysts expect that Shire PLC will post $14.92 earnings per share for the current year.

The firm also recently announced a semiannual dividend, which will be paid on Friday, October 20th. Shareholders of record on Friday, September 8th will be issued a dividend of $0.1527 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a yield of 0.21%. Shire PLC’s dividend payout ratio (DPR) is presently 40.63%.

COPYRIGHT VIOLATION NOTICE: “HL Financial Services LLC Boosts Stake in Shire PLC (SHPG)” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/hl-financial-services-llc-boosts-stake-in-shire-plc-shpg/1493505.html.

A number of equities analysts have recently commented on SHPG shares. Piper Jaffray Companies set a $159.00 target price on shares of Shire PLC and gave the stock a “hold” rating in a research report on Wednesday, July 26th. Zacks Investment Research lowered shares of Shire PLC from a “hold” rating to a “sell” rating in a research report on Monday, July 17th. Sanford C. Bernstein lowered shares of Shire PLC from an “outperform” rating to a “market perform” rating and reduced their target price for the stock from $209.22 to $161.09 in a research report on Thursday, May 25th. BidaskClub lowered shares of Shire PLC from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 5th. Finally, HSBC Holdings plc lowered shares of Shire PLC from a “hold” rating to a “reduce” rating in a research report on Friday, May 19th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $222.27.

Shire PLC Company Profile

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).

Institutional Ownership by Quarter for Shire PLC (NASDAQ:SHPG)

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.